PRESS RELEASE : Protera Appoints Novozymes Executive Thomas Videbaek As Chair of the Board of Directors and Non-Executive Board Member

DGAP-News: Protera SAS / Key word(s): Personnel 
Protera Appoints Novozymes Executive Thomas Videbaek As Chair of the Board of Directors and Non-Executive Board Member 
2021-04-06 / 08:00 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
Protera Appoints Novozymes Executive Thomas Videbaek As Chair of the Board of Directors and Non-Executive Board Member 
SANTIAGO, CHILE and PARIS, FRANCE / ACCESSWIRE / April 6, 2021 / Protera, an AI-driven startup designing and developing 
new proteins to enable a wide range of natural and sustainable solutions, announced today it has appointed Novozymes 
senior executive Thomas Videbaek as Chair of the Board of Directors and non-executive board member. 
Dr. Videbaek has spent the last 13 years on the executive team at Novozymes, the world leader in industrial enzymes. 
After three decades at the firm, which included positions in Europe and the U.S., Dr. Videbaek will transition to focus 
on his career as a professional board member. Dr. Videbaek has a Bachelor in Business Administration from the 
Copenhagen Business School, and a PhD and MSc from the Technical University of Denmark. 
Most recently, Dr. Videbaek was Executive Vice President (EVP) of Corporate Strategy & Business Transformation at 
Novozymes. Previously, he held a number of senior business development roles, most recently as EVP. Dr. Videbaek has 
also led initiatives that created a number of new business areas for the firm, including the now significant microbial 
area of bio agriculture, as well as supply chain operations, where he helped build a global supply chain organization. 
Protera is developing the manufacturing process to deliver commercially viable proteins designed using its proprietary 
madi(TM) technology. Dr. Videbaek's experience in the field and strategic vision will be crucial to scaling up and 
strengthening Protera's commercial position with partners along the food value chain. 
Leonardo Álvarez, CEO and co-founder of Protera, said: "Thomas is a leader in the field with over 30 years of 
experience at the world's largest enzyme company. His proven track-record in the commercial, operational and research 
sides of business, and deep understanding of the challenges that encompass new functional proteins, will help us 
consolidate Protera's position in the industry". 
Josko Bobanovic, Partner at Sofinnova Partners and also a member of Protera's board of directors, noted, "Thomas' 
global corporate strategy development skills as well as his ability to convert technical discoveries into new 
businesses, make him well-equipped to help accelerate Protera from pilot-stage to a commercially viable market player 
poised to address the significant sustainability challenges across food, agriculture and other markets." 
Dr. Videbaek said, "I am delighted to join Protera as the Chair of the Board at this exciting time of growth and 
expansion at the company. I strongly believe Protera has the tools to offer a powerful solution for global food 
producers and ultimately, sustainable alternatives for consumers. Over the longer term, Protera will continue to play a 
leadership role in protein development, helping to address a broad range of sustainability issues." 
About Protera 
Protera is advancing the science of protein engineering to address some of the most critical problems and opportunities 
in food, agriculture, the environment and human health. We streamline protein design and development with madi(TM), our 
proprietary deep learning algorithm, to predict high value protein products and enzymes with unprecedented speed and 
accuracy. http://proterabio.com 
Media Contact 
Kate Barrette 
RooneyPartners LLC 
+1.212.223.0561 
[e-mail] 
SOURCE: Protera SAS 
=---------------------------------------------------------------------------------------------------------------------- 
2021-04-06 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. 
The issuer is solely responsible for the content of this announcement. 
The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. 
Archive at www.dgap.de 
=---------------------------------------------------------------------------------------------------------------------- 

1180826 2021-04-06

(END) Dow Jones Newswires

April 06, 2021 02:02 ET (06:02 GMT)